This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Universitè De Genève. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: David Pejoski - Innovator in Cancer Treatment
Introduction
David Pejoski is an inventor based in Geneva, Switzerland. He is affiliated with the Université de Genève, where he contributes to research in the field of cancer treatment. Although he currently holds no granted patents, his work focuses on innovative approaches to medical therapies.
Latest Patent Applications
David Pejoski's latest patent application is titled "Adenosine 2A Receptor Modulators for Use in the Treatment of Cancer." This invention relates to new agents that are useful in the treatment of cancers, particularly through immunotherapy. The application details new A2AR modulators, pharmaceutical compositions, and their uses in cancer treatment.
Conclusion
David Pejoski is dedicated to advancing cancer treatment through innovative research and development. His contributions to the field, particularly in the area of adenosine receptor modulators, hold promise for future therapeutic applications.